Samsara BioCapital GP, LLC - 30 May 2024 Form 4 Insider Report for CARGO Therapeutics, Inc. (CRGX)

Reporting relationship: 10%+ Owner
Issuer ticker: CRGX
Reported as of: 30 May 2024
Net transaction value: +$4,998,000
SEC form: 4
Accepted by SEC: 03 Jun 2024, 21:45:28 UTC
Prior SEC filing: 06 Dec 2024
Next SEC filing: 27 Nov 2024
Source filing: View source filing
Reporting owner signature: Samsara BioCapital GP, LLC, By /s/ Srinivas Akkaraju, Managing Member

Key filing fact

Samsara BioCapital GP, LLC filed Form 4 for CARGO Therapeutics, Inc. (CRGX) on 03 Jun 2024.

Key facts

This page summarizes Samsara BioCapital GP, LLC's Form 4 filing for CARGO Therapeutics, Inc. (CRGX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2024, 21:45.

Change

Previous filing in this sequence was filed on 06 Dec 2024.
Current net transaction value: +$4,998,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRGX transaction

Common Stock

Purchase

Transaction value: $4,998,000
Shares: +294,000
Change %: +7.1%
Price: $17.00
Shares after: 4,415,689
Date: 30 May 2024
Ownership: By Samsara BioCapital, L.P.
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Samsara BioCapital GP, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Shares are held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein.